• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Researcher gets $2.7 million grant to study seasonal and universal vaccination in aged populations

Bioengineer by Bioengineer
September 6, 2025
in Chemistry
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

ATLANTA–Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.7 million federal grant to study seasonal and universal vaccination in elderly populations with pre-existing immunity to influenza viruses.

The grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases will be used to determine if a new universal vaccine that induces immunity using multiple influenza proteins will enhance the range and efficacy of cross protection against different influenza virus strains in adult and aged populations with or without pre-existing immunity.

“The outcomes in this project will be highly significant in the aspect of translational science and relevance to improve the cross protective efficacy of flu vaccination,” Kang said.

People age 65 and older are at high risk of developing serious flu-related complications if they become ill from the flu, some of which can be life-threatening and result in death, according to the Centers for Disease Control and Prevention.

Seasonal flu vaccines, which are based on a highly variable influenza protein called hemagglutinin, fail to provide effective cross protection against different types of influenza viruses. The efficacy of these vaccines is particularly low in aged populations, even among individuals with pre-existing immunity to influenza.

In aged populations, the impact of pre-existing immunity on the effectiveness of universal and seasonal vaccination and immunogenicity, the ability of therapeutic protein products to stimulate an immune response, are not well understood. Developing flu vaccination strategies that improve cross protective efficacy in young and aged hosts with pre-existing immunity is of high priority.

This project will test whether new universal vaccines that induce immunity to multiple influenza virus protein targets – M2 extracellular domain, hemagglutinin-stalk domains and neuraminidase – will improve the range and efficacy of cross protection against seasonal variants and pandemic potential flu viruses in adult and aged animals with or without pre-existing immunity.

###

For more information about the grant, visit https://reporter.nih.gov/search/tTuPNzr7l0C_u2PIGtc51A/project-details/10313001.

Media Contact
LaTina Emerson
[email protected]

Original Source

https://news.gsu.edu/2021/06/04/biomedical-sciences-researcher-gets-2-7-million-federal-grant-to-study-seasonal-and-universal-vaccination-in-aged-populations/

Tags: AgingGerontologyImmunology/Allergies/AsthmaInfectious/Emerging DiseasesMedicine/HealthPharmaceutical ScienceVaccines
Share12Tweet8Share2ShareShareShare2

Related Posts

Covalent Organic Frameworks: Building Infinite Metal–Organic Structures

Covalent Organic Frameworks: Building Infinite Metal–Organic Structures

October 7, 2025
blank

Next-Generation Perovskite Solar Cells Near Commercialization Milestone

October 7, 2025

Unlocking Clean Energy: Harvesting Hydrogen from Biomass Significantly Cuts Carbon Emissions

October 7, 2025

Innovative Prediction Model Promises Enhanced Reliability for Fusion Power Plants

October 7, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    910 shares
    Share 364 Tweet 227
  • New Study Reveals the Science Behind Exercise and Weight Loss

    98 shares
    Share 39 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    94 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    77 shares
    Share 31 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Brain-on-a-Chip Technology Uncovers Mechanisms of Brain Damage in Sepsis and Neurodegenerative Diseases

Paul Boutros Appointed Director of Cancer Center at Sanford Burnham Prebys

Leading Scientific Breakthroughs Honored at ACC Middle East Conference

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.